|Videos|June 29, 2022
Future Perspectives in Renal Cell Carcinoma (RCC)
Author(s)Thomas Hutson, DO, PharmD
Dr Thomas Hutson comments on the TiNivo-2 trial and discusses upcoming and novel therapies for patients with renal cell carcinoma.
Advertisement
Advertisement
Related to this article
FDA approves Welireg plus Lenvima for advanced clear cell kidney cancer after PD-1 or PD-L1 treatment, offering a new treatment option.
Advertisement
Advertisement